Inventor · disambiguated record
James Veltmeyer
Also filed as: VELTMEYER JAMES · VELTMEYER JAMES D
5 granted patents·46 pending applications·11 citations·filing 1998–2025
70Inventor score
Files withTHERAPEUTIC SOLUTIONS INT INC40VELTMEYER JAMES6ICHIM THOMAS E2SPHERE THERAPEUTICS INC1THERAPUTIC SOLUTIONS INT INC1
Top patents by PatentIndex Score
51 records- 0193US11229674B1Nutraceuticals for suppressing indolamine 2,3 deoxygenaseICHIM THOMAS E·Filed 2020·Granted Jan 25, 2022·7 cites·19 claims
- 0290US11504410B2Neuroprotection and neuroregeneration by pterostilbene and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Nov 22, 2022·2 cites·19 claims
- 0366US2024076679A1Gene silencing therapy of acute respiratory disorderTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0464US12011462B2Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Granted Jun 18, 2024·0 cites·12 claims
- 0564US2024366677A1Aneurysm Treatment by ExosomesTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 0663US2024156862A1Treatment of chronic obstructive pulmonary disease with myeloid derived suppressor cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0763US2024307446A1Generation and Utility of B Cell Subsets for Treatment of Chronic Obstructive Pulmonary DiseaseTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 0863US2024034996A1Gene modified ipsc derived cellular compositions for regeneration and immune modulationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0962US2024241119A1Prediction of stem cell therapy responsiveness by quantification of pre-existing b regulatory cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1062US2024082356A1Treatment of copd by stimulation of stem cell mobilizationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1162US2024050485A1Treatment of chronic obstructive pulmonary disease by mesenchymal stem cell apoptotic bodies and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1261US2023364148A1Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell regenerationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1361US2024269148A1Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic AgentsTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1461US2024011006A1Methods and means of inactivating rna based vaccinesVELTMEYER JAMES·Filed 2023·Application pending·0 cites
- 1560US2024226172A9Mesenchymal stem cell therapy of epilepsy and seizure disordersTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1660US2024216472A1Enhanced efficacy of tolerogenic vaccinationTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1759US2024091269A1Treatment of bipolar disorder using mesenchymal stem cells and modification of mesenchymal stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1858US2024082365A1Multidisciplinary treatment of chronic disease using regenerative cells and technologiesVELTMEYER JAMES·Filed 2023·Application pending·0 cites
- 1958US2024115678A1Personalized multidisciplinary cancer therapyVELTMEYER JAMES·Filed 2023·Application pending·0 cites
- 2057US2022267730A1Ex vivo generation of immunocytes recognizing brother of the regulator of imprinted sites (boris) expressing cancer stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2157US2023303973A1Generation of tumor immunity using astrocytes and astrocyte-dendritic cell combinationsVELTMEYER JAMES·Filed 2023·Application pending·0 cites
- 2257US2022306994A1Chimeric cells comprising dendritic cells and endothelial cells resembling tumor endotheliumTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2356US2022298491A1Pluripotent stem cell derived dendritic cells and engineered dendritic cells for cancer immunotherapyTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2456US2023047535A1Induction of neurogenesis using umbilical cord derived mesenchymal stem cells and derivatives thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2556US2023057957A1Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degenerationTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2656US2023201268A1Treatment of cancer by administration of neurons and derivatives thereofVELTMEYER JAMES·Filed 2022·Application pending·0 cites
- 2756US2024418706A1Quantification of circulating regenerative and endothelial progenitor cells as predictors of health statusVELTMEYER JAMES·Filed 2023·Application pending·0 cites
- 2856US2022235325A1Stimulation of dendritic cell activity by homotaurine and analogues thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2955US2022370561A1Lithium as a monotherapy and/or stem cell adjuvant therapy for pulmonary fibrosisTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3055US2023010501A1Treatment of parkinson's disease by immune modulation and regenerative meansTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3155US2023192901A1Induction of concurrent pulmonary immune modulation and regeneration by protein mediated conjugation of immune regulatory cells with endogenous progenitor cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3254US2023085607A1Ivermectin compositions for treatment of covid-19THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3354US2022323547A1Amelioration and Treatment of Opioid AddictionTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3454US2023107484A1Reduction of neutrophil extracellular trap formation by mesenchymal stem cells and their exosomesTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3553US2022143123A1Prevention of Pathological Coagulation in COVID-19 and other Inflammatory ConditionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3653US2022403330A1Compositions capable of stimulating immunity towards tumor blood vesselsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3753US2022096542A1Augmentation of natural killer cell activity and induction of cytotoxic immunity using leukocyte lysate activated allogeneic dendritic cells: stemvacsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3853US2022023237A1Additive and/or synergistic combinations of metformin with nutraceuticals for the prevention, inhibition and treatment of sars-cov-2 and associated covid-19THERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3953US2022249551A1Stimulation of natural kill cell memory by administration of dendritic cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4052US11957727B2Prevention of neuroinflammation associated memory loss using nutraceutical compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Apr 16, 2024·0 cites·10 claims
- 4151US2023057356A1Enhancement of umbilical cord mesenchymal stem cell therapeutic activity by stimulators of t regulatory cells and/or cells expressing cd73THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4251US2022370499A1Immunotherapies for targeting of tumor vasculatureTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4351US2022280574A1Therapeutic monocytes for prevention of suicidal ideationTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4451US2022395540A1Treatment of covid-19 lung injury using umbilical cord plasma based compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4550US2022175701A1Treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal neurogenesis utilizing plant-based approachesTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4649US2022193127A1Immunotherapy for opioid addictionTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4749US2021393681A1Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive ImmunityICHIM THOMAS E·Filed 2020·Application pending·0 cites
- 4848US2021386815A1Nutraceuticals for Reducing Myeloid Suppressor CellsTHERAPUTIC SOLUTIONS INT INC·Filed 2020·Application pending·0 cites
- 4946US2023333117A1Methods of determining risk of suicide by immunological assessmentTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 5039US2025241961A1Stem cell immunotherapy for colitisSPHERE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →